ALAMEDA, Calif., Nov. 2, 2023 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the third quarter ended September 30, 2023. Revenue of $270.9 million in the third quarter of 2023, an increase of 26….
